Home Cart Sign in  
Chemical Structure| 2649788-46-3 Chemical Structure| 2649788-46-3

Structure of LY3537982
CAS No.: 2649788-46-3

Chemical Structure| 2649788-46-3

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

KRAS G12C Inhibitor 19 is a specific inhibitor targeting the KRAS G12C mutation, which intervenes in tumor cell growth by targeting the KRAS G12C mutation site. It shows potential in the treatment of various cancers.

Synonyms: Olomorasib; KRAS G12C inhibitor 19

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of LY3537982

CAS No. :2649788-46-3
Formula : C25H19ClF2N4O3S
M.W : 528.96
SMILES Code : N#CC1=C(N)SC2=C(F)C=CC(C3=C(F)C=C4C(OCC[C@](CN(C(C=C)=O)CC5)([H])N5C4=O)=C3Cl)=C21
Synonyms :
Olomorasib; KRAS G12C inhibitor 19
MDL No. :N/A

Safety of LY3537982

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of LY3537982

GPCR

Isoform Comparison

Biological Activity

Description
KRAS G12C inhibitor 19 is a potent inhibitor targeting KRAS G12C. It notably suppresses tumor growth (extracted from patent WO2021118877A1)[1].

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT06235983 Advanced Solid Tumors PHASE1 ACTIVE_NOT_RECRUITING 2025-04-27 Jilin Cancer Hospital, Changch... More >>un, Jilin, 132000, China|The First Affiliated Hospital, Zhejiang University, Hangzhou, Zhejiang, 310003, China|Zhejiang Cancer Hospital, Hangzhou, Zhejiang, 310022, China Less <<
NCT05824858 Healthy PHASE1 COMPLETED 2023-06-17 ICON, Salt Lake City, Utah, 84... More >>124, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.89mL

0.38mL

0.19mL

9.45mL

1.89mL

0.95mL

18.91mL

3.78mL

1.89mL

References

 

Historical Records

Categories